Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Clinical Trials In Review: Big Hits And Misses In 2018

2019 2018 Perspectives

Related Content

New Cholesterol Guidelines Follow Long History Of Failed Outcomes Trials

Dec 02 2013

Axovant Builds A Case For GSK’s 5-HT6 Castoff In Alzheimer’s

Aug 03 2015

Keeping Track: US FDA Clears Novel Flu Treatment Xofluza, Boosts Trintellix Label With Sexual Dysfunction Data

Oct 29 2018

More Alzheimer's Pain As J&J Pulls Plug On BACE Inhibitor

May 18 2018

Stellar Survival Data For AZ's Lynparza Hailed At ESMO

Oct 22 2018

Biogen's Busy Pipeline: Continued Confusion On BAN2401, But Other Irons In The Fire

Oct 26 2018

Merck Hits IO Bullseye With Keytruda Combo In First-line Lung Cancer

Jan 17 2018

Pfizer Pulls Plug But iTeos Has High Hopes For IDO1 Inhibitor

Jan 04 2018

Axovant's Cupboard Is Bare After Lead Dementia Program Fails

Jan 09 2018

Lilly’s Solanezumab Fails, But The Surprise Would Have Been Success

Nov 23 2016

Alzheimer's Prevention: The Next Big Idea For Fixing Drug Trial Failures

Sep 28 2017

Amarin, Omthera dip after study knocks fish oil benefit

May 10 2013

'Total Disaster' In First-Line Lung Cancer For BMS's Opdivo

Oct 10 2016

MYSTIC Misses: Devastation For AstraZeneca As Imfinzi Fails PFS Endpoint In NSCLC

Jul 27 2017

The Year's Clinical Trials In Review: Big Hits In 2017

Dec 28 2017

Imbruvica Replaces Chemo, Darzalex Boosts Standard Of Care In Front-Line CLL, Myeloma

Dec 05 2018

Roche/Abbvie's Venclexta Outshines Agios IDH Inhibition In AML At ASH

Dec 05 2018

AZ Goes Into The MYSTIC And Finds Positives For Imfinzi

Dec 14 2018

After Imbruvica Passes Chemo-Free Tests, Shorter Duration Regimens Could Be Next Value-Adds

Dec 13 2018

Axovant Closes Chapter On Failed, Second-Rate Small Molecule Strategy

Dec 11 2018

Roche's Tecentriq Becomes Second In PD-1/L1 Family To Gain First-Line Lung Cancer Approval

Dec 07 2018

AML Paradigm Shift: Doctors Welcome Many New Approvals And Approaches

Dec 06 2018

Merck KGAA/Pfizer's Bavencio Failure Casts More Shade On Immunotherapy For Ovarian Cancer

Dec 24 2018

First-Line Ovarian Cancer Approval Solidifies Lead For AstraZeneca's Lynparza

Dec 19 2018

GSK Embraces PARP Promise With Tesaro Buy

Dec 03 2018

SOLO-3 Adds To AZ/MSD’s Lynparza’s Ovarian Cancer Success Tally But Impact Minimal

Dec 20 2018

M&A Pressure Mounts For Merck & Co After Alzheimer's Drug Dismissed

Feb 14 2018

Boehringer Shoots For Schizophrenia With PDE9 Inhibitor, Ends Alzheimer's R&D

Feb 09 2018

Biogen Spooks With Phase III Aducanumab Changes

Feb 15 2018

Amarin's REDUCE-IT Data For Vascepa May Be Game-Changing, But Not Without Controversy

Nov 13 2018

More Good News For AML As Pfizer And AbbVie/Roche Drugs Get FDA Okay

Nov 22 2018

Roche's IMpower150 Gets AACR Applause But Merck's KEYNOTE-189 Big Winner

Apr 17 2018

Incyte/Merck's ECHO-301 Failure Casts More Shadow On IDO Space

Apr 06 2018

ARCTIC Chill Descends On AstraZeneca's Imfinzi/Treme Combo In NSCLC

Apr 24 2018

A Wake For IDO: Bristol Ends Registrational Trials Of High-Priced Flexus Drug

Apr 30 2018

IMpower132 Casts More Doubt On Roche's Tecentriq In First-Line NSCLC

Sep 26 2018

Neuroscience Is The Next Oncology: Why Biogen Is Doubling Down

Nov 23 2018

Ovarian Cancer Pipeline Review: Sponsors Plan Frontline Punch, Smart Combinations

Dec 07 2018

Ovarian Cancer Market Snapshot: AstraZeneca's Lynparza Poised To Lead In Niche Space

Dec 07 2018

Mystic Miss Not Make Or Break For Imfinzi

Nov 16 2018

Scant Pipeline Competition For Roche’s Novel Flu Antiviral

Jun 26 2018

TMB Biomarker Is A Winding Path Rather Than Straight Road

Jun 14 2018

Lilly Stays Committed To Alzheimer's, Including Amyloid Hypothesis, Despite Many Failures

Jun 14 2018

PCSK9 Turning Point? Sanofi/Regeneron Dangle Lower Price Carrot For Praluent

Mar 13 2018

Roche Steps Closer To Flu Market Domination With Phase III Baloxavir Results

Jul 17 2018

First-Line Chemo Combo Data Help Merck's Keytruda Power Past Opdivo

Jul 30 2018

NewLink Absorbs Big Blow As Roche Exits IDO Inhibitor Partnership

Jun 08 2017

ASH Data Drive Momentum For Revolution In CLL Treatment

Dec 14 2015

Related Companies

Pfizer Inc.

iTeos Therapeutics Inc.

Additional Topics

Clinical Trials Approvals Research & Development Cancer Cardiovascular Neurology BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window